ALXN RSI
As of date:11/30/2020
ALXN stock price:122.11
ALXN RSI:42.28
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)42.28
Extremely
Oversold

Also see:
ALXN Market Cap History
ALXN Shares Outstanding History
ALXN YTD Return
ALXN DMA
ALXN MACD
ALXN Technical Analysis

BTAI Crosses Below Key Moving Average Level
1 hour, 12 minutes ago


PS Makes Bullish Cross Above Critical Moving Average
1 hour, 13 minutes ago


MeiraGTx Holdings (MGTX) Shares Cross Below 200 DMA
1 hour, 14 minutes ago


EQX Makes Bullish Cross Above Critical Moving Average
1 hour, 41 minutes ago


Bullish Two Hundred Day Moving Average Cross - TXG.CA
1 hour, 51 minutes ago


UUP Crosses Critical Technical Indicator
1 hour, 51 minutes ago


NFG Crosses Below Key Moving Average Level
1 hour, 51 minutes ago


Bullish Two Hundred Day Moving Average Cross - CG.CA
2 hours, 9 minutes ago


SIMO Crosses Above Key Moving Average Level
6 hours, 7 minutes ago


Inseego Breaks Above 200-Day Moving Average - Bullish for INSG
6 hours, 7 minutes ago


DVAX Makes Bullish Cross Above Critical Moving Average
6 hours, 7 minutes ago


Bullish Two Hundred Day Moving Average Cross - SSRM
6 hours, 7 minutes ago


ILMN Makes Bullish Cross Above Critical Moving Average
6 hours, 7 minutes ago


Alnylam Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for ALNY
6 hours, 7 minutes ago


QUOT Crosses Above Key Moving Average Level
6 hours, 42 minutes ago


More Technical Analysis News

ALXN RSIALXN DMA
Alexion Pharmaceuticals is a biopharmaceutical company serving patients and families affected by rare diseases through the discovery, development and commercialization of therapies. Co. has developed and commercialized two complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome, as well as the complement inhibitor to treat anti-acetylcholine receptor antibody-positive generalized myasthenia gravis and neuromyelitis optica spectrum disorder in patients who are anti-aquaporin-4 antibody positive. In addition, Co. has two enzyme replacement therapies for metabolic disorders, hypophosphatasia and lysosomal acid lipase deficiency.

When researching a stock like Alexion Pharmaceuticals, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from ALXN Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for ALXN stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of these ways is called the Relative Strength Index, or RSI. This popular indicator, originally developed in the 1970's by J. Welles Wilder, looks at a 14-day moving average of a stock's gains on its up days, versus its losses on its down days. The resulting ALXN RSI is a value that measures momentum, oscillating between "oversold" and "overbought" on a scale of zero to 100. A reading below 30 is viewed to be oversold, which a bullish investor could look to as a sign that the selling is in the process of exhausting itself, and look for entry point opportunities. A reading above 70 is viewed to be overbought, which could indicate that a rally in progress is starting to get crowded with buyers. If the rally has been a long one, that could be a sign that a pullback is overdue.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes
Get Free SEC filing alerts for ALXN:
ALXN SEC Filing Email Alerts ServiceExternal link
Video: RSI Indicator


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Alexion Pharmaceuticals (ALXN) is categorized under the Healthcare sector; to help you further research RSI, below are some other companies in the same sector:

AMGN RSI
BAX RSI
BDX RSI
BIIB RSI
BMY RSI
BSX RSI
CAH RSI
CELG RSI
CNC RSI
COO RSI
More Healthcare companies »

 

ALXN RSI | www.StockRSI.com | Copyright © 2019 - 2020, All Rights Reserved

Nothing in StockRSI.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.